Home › Funds › Avoro Capital Advisors LLC › FTH
Avoro Capital Advisors LLC position in FTH
FAETH THERAPEUTICS INC
Avoro Capital Advisors LLC reported holding 1,410,000 shares of FTH (FAETH THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$41.9M, representing 0.43% of its reported portfolio and ranking #24 among its reported holdings. Avoro Capital Advisors LLC has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's FTH position evolved
Avoro Capital Advisors LLC first disclosed a stake in FTH in Q2 2026 at 1,444,039 shares (US$36.1M). The position peaked in Q3 2026 at 1,410,000 shares, worth US$41.9M. Across 2 filings, Avoro Capital Advisors LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,410,000 shares valued at US$41.9M — a reduction of -34,039 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.44M | $36.10M | New |
| Q3 2026 | 1.41M | $41.93M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FTH and 13F data
FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 72 other funds we track also report a position in FTH — the largest reported positions include MONTANOVA CAPITAL, LLC (US$50.5M), BAKER BROS. ADVISORS LP (US$32.2M), Trails Edge Capital Partners, LP (US$28.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FTH
- MONTANOVA CAPITAL, LLC 2.02M sh · $50.50M · Q2 2026
- BAKER BROS. ADVISORS LP 1.29M sh · $32.16M · Q2 2026
- Trails Edge Capital Partners, LP 941.69K sh · $28.01M · Q3 2026
- Vivo Capital, LLC 844.58K sh · $25.12M · Q3 2026
- B Group, Inc. 610.17K sh · $18.15M · Q3 2026
- Fairmount Funds Management LLC 722.02K sh · $18.05M · Q2 2026
- Caligan Partners LP 629.47K sh · $15.74M · Q2 2026
- STEMPOINT CAPITAL LP 404.92K sh · $12.04M · Q3 2026
- Octagon Capital Advisors LP 361.01K sh · $9.03M · Q2 2026
- Cormorant Asset Management, LP 1.03M sh · $7.66M · Q2 2026
- Boxer Capital Management, LLC 180.50K sh · $4.51M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 124.10K sh · $3.69M · Q3 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held FTH?
Avoro Capital Advisors LLC has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Avoro Capital Advisors LLC's current position in FTH?
As of Q3 2026, Avoro Capital Advisors LLC holds 1.41M shares of FTH (FAETH THERAPEUTICS INC), valued at $41.93M, representing 0.43% of its reported portfolio and ranking #24.
Has Avoro Capital Advisors LLC been buying or selling FTH?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC reduced its position in FTH. The position peaked in Q3 2026 at 1.41M shares.
Which other funds hold FTH?
Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, BAKER BROS. ADVISORS LP, Trails Edge Capital Partners, LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.